title: Site of action of a pentapeptide agonist at the glucagon-like peptide-1 receptor. Insight into a small molecule agonist-binding pocket.
abstract: The development of small molecule agonists for class B G protein-coupled receptors (GPCRs) has been quite challenging. With proof-of-concept that exenatide, the parenterally administered peptide agonist of the glucagon-like peptide-1 (GLP1) receptor, is an effective treatment for patients with diabetes mellitus, the development of small molecule agonists could have substantial advantages. We previously reported a lead for small molecule GLP1 receptor agonist development representing the pentapeptide NRTFD. In this work, we have prepared an NRTFD derivative incorporating a photolabile benzoylphenylalanine and used it to define its site of action. This peptide probe was a full agonist with potency similar to NRTFD, which bound specifically and saturably to a single, distinct site within the GLP1 receptor. Peptide mapping using cyanogen bromide and endoproteinase Lys-C cleavage of labeled wild type and M397L mutant receptor constructs identified the site of covalent attachment of NRTFD within the third extracellular loop above the sixth transmembrane segment (TM6). This region is the same as that identified using an analogous photolabile probe based on secretin receptor sequences, and has been shown in mutagenesis studies to be important for natural agonist action of several members of this family. While these observations suggest that small molecule ligands can act at a site bordering the third extracellular loop to activate this class B GPCR, the relationship of this site to the site of action of the amino-terminal end of the natural agonist peptide is unclear.
authors.affiliation: Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA. dongmq@mayo.edu
authors.forename: Maoqing
authors.initials: M
authors.lastname: Dong
authors.forename: Delia I
authors.initials: DI
authors.lastname: Pinon
authors.forename: Laurence J
authors.initials: LJ
authors.lastname: Miller
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D016466:CHO Cells; D002460:Cell Line; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D006224:Cricetinae; D003412:Cricetulus; D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D000067757:Glucagon-Like Peptide-1 Receptor; D006801:Humans; D008024:Ligands; D008666:Metalloendopeptidases / Q000737:chemistry; D008956:Models, Chemical; D008969:Molecular Sequence Data; D016296:Mutagenesis; D010455:Peptides / Q000737:chemistry*; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D018027:Receptors, Glucagon / Q000819:agonists*
chemical_list: C000593833:GLP1R protein, human; D000067757:Glucagon-Like Peptide-1 Receptor; D008024:Ligands; D010455:Peptides; D018027:Receptors, Glucagon; D008666:Metalloendopeptidases; C039830:peptidyl-Lys metalloendopeptidase
references.citation: J Biol Chem. 2009 Aug 14;284(33):21839-21847
references.pmid: 19447889
references.citation: Biochem Pharmacol. 2006 Jul 14;72(2):244-55
references.pmid: 16750175
references.citation: J Biol Chem. 2004 Jan 23;279(4):2894-903
references.pmid: 14593094
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):689-90
references.pmid: 17213306
references.citation: Biochemistry. 2010 Mar 9;49(9):1862-72
references.pmid: 20099900
references.citation: J Biol Chem. 2004 Jul 23;279(30):31177-82
references.pmid: 15155765
references.citation: Mol Endocrinol. 2008 Jun;22(6):1489-99
references.pmid: 18372345
references.citation: Mol Pharmacol. 2003 Jun;63(6):1256-72
references.pmid: 12761335
references.citation: Int J Pharm. 2009 Jan 21;366(1-2):218-20
references.pmid: 19027057
references.citation: J Biol Chem. 1998 Aug 28;273(35):22498-505
references.pmid: 9712875
references.citation: Diabetologia. 2001 Nov;44(11):2018-24
references.pmid: 11719833
references.citation: J Biol Chem. 2011 Jul 8;286(27):23888-99
references.pmid: 21566140
references.citation: Trends Biochem Sci. 2009 Jun;34(6):303-10
references.pmid: 19446460
references.citation: Int J Pept Protein Res. 1988 May;31(5):429-34
references.pmid: 3410633
references.citation: Structure. 2010 Sep 8;18(9):1083-93
references.pmid: 20826335
references.citation: Mol Pharmacol. 2006 Jul;70(1):206-13
references.pmid: 16531505
references.citation: Nat Clin Pract Endocrinol Metab. 2005 Nov;1(1):22-31
references.pmid: 16929363
references.citation: J Biol Chem. 2002 Apr 19;277(16):14294-8
references.pmid: 11847213
references.citation: J Biol Chem. 2010 Mar 26;285(13):9919-9931
references.pmid: 20100828
references.citation: J Biol Chem. 2010 Aug 6;285(32):24508-18
references.pmid: 20529866